What is NGL Fine Chem Ltd (NGLFINE) share price today?

NGL Fine Chem Ltd (NGLFINE) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/NGLFINE for the latest live price, technical analysis, and AI-powered insights.

How to analyse NGLFINE stock?

VestAI provides comprehensive NGLFINE stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is NGL Fine Chem Ltd in?

NGL Fine Chem Ltd (NGLFINE) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

NGL Fine Chem Ltd

Q: What is NGL Fine Chem Ltd's Orion Score?

NGL Fine Chem Ltd has an Orion Score of 63/100 (Watch) — a fundamentals-based quality & risk score. NGL Fine Chem Ltd scores 63/100 (Watch) on the Orion Score — moderate business quality (56), strong growth (87), strong balance-sheet safety (71) and rich valuation (39). A fundamentals-based quality & risk score, not a buy/sell recommendation.

NGLFINE

NSE· Healthcare

₹3,136.50

-57.10 (-1.79%)

Updated 04:16 am IST

52W Low · ₹1,175.5052W High · ₹3,319.80

Near 52W High

Market Cap

₹1694.38L Cr

Volume

459

Prev Close

₹3,193.60

ISIN

INE887E01022

Orion Score

Fundamentals-based quality & risk · not a recommendation

63/100

Watch

NGL Fine Chem Ltd scores 63/100 (Watch) on the Orion Score — moderate business quality (56), strong growth (87), strong balance-sheet safety (71) and rich valuation (39). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Short track record (4 yrs of data)

Forensic accounting

Piotroski F 5/9Altman Z Safe(6.85)Beneish M Elevated(-2.00)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

83/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.33x — lean balance sheet

QUALITY

Average

ROCE 13.4% — decent returns

MOMENTUM

Neutral

RSI 60.1 — consolidating

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 35.18
ROCE: 13.43%
ROE (1Y): 15.74%
D/E Ratio: 0.33x
OPM: 10.96%
TTM EPS: ₹77.97
Dividend Yield: 6.00%
Qtrly Sales: ₹149.23 Cr
Qtrly Profit: ₹13.49 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹149.23	₹13.49	11.0%	₹21.83
Q3 2026	₹127.51	₹15.69	13.4%	₹25.40
Q2 2026	₹120.26	₹9.63	10.0%	₹15.58
Q1 2026	₹104.19	₹9.24	6.4%	₹14.96
Q4 2025	₹94.97	₹0.54	3.2%	₹0.88

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹500.95	₹48.13	₹87.42	10.6%
FY 2025	₹368.26	₹21.12	₹42.5	5.8%
FY 2024	₹333.71	₹41.32	₹67.4	12.6%
FY 2023	₹273.57	₹20.5	₹39.85	8.7%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
NGLFINE ★	₹1,694 Cr	35.18	13.43%	15.74%	0.33x	10.96%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹433.39	₹355.54	₹287.08	₹276.93
Equity	₹282.43	₹262.63	₹222.55	₹203.22
Total Debt	₹77.1	₹34	₹32.5	₹30
Cash	₹0.58	₹0.4	₹7.83	₹0.64
Net Debt	₹76.51	₹33.61	₹24.67	₹29.36
Working Capital	₹116.41	₹126.08	₹104.36	₹107.84

Shareholding Pattern

Q1 FY2027

Promoter

72.74%

FII

DII

Public

27.26%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	72.74%	0%	0%	27.26%
Q3 FY2026	72.74%	0%	0%	27.26%
Q2 FY2026	72.74%	0%	0%	27.26%
Q1 FY2026	72.74%	0%	0%	27.26%
Q4 FY2025	72.74%	0% ↓	0%	27.26% ↑
Q3 FY2025	72.74%	0.05% ↑	0%	27.23% ↓
Q2 FY2025	72.74%	0.02%	0%	27.25% ↑
Q1 FY2025	72.74%	0.03%	0%	27.24%

Corporate Actions

No recent corporate actions

Analyse NGLFINE with Orion AI

Ask: "Is NGL Fine Chem Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About NGL Fine Chem Ltd (NGLFINE) Stock

NGL Fine Chem Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE887E01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.